Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Hematology & Oncology|April 24, 2024
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trialJie Xu, Bai-Yan Wang, Shan-He Yu, et al.
Haematologica|February 15, 2024
ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpressionWenqian Xu, Feng Tian, Xiaolu Tai, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2025
Prognostic value of [18F]fluorodeoxyglucose-PET/MRI(CT) novel interpretation criteria (IMPeTUs) in multiple myelomaMiao Zhang, Tangjia Cai, Shiwei Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2013
Preferential eradication of acute myelogenous leukemia stem cells by fenretinideHui Zhang, Jian-Qing Mi, Hai Fang, et al.
Journal of Proteome Research|September 4, 2013
Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysisYihuang Wang, Limin Zhang, Wen-Lian Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.
Nature Genetics|March 15, 2011
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemiaXiao-Jing Yan, Jie Xu, Zhao-Hui Gu, et al.
JAMA Oncology|November 7, 2024
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical TrialChunrui Li, Keshu Zhou, Yongxian Hu, et al.
Signal Transduction and Targeted Therapy|December 7, 2023
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicityYan Sun, Xiu-Na Yang, Shuang-Shuang Yang, et al.
European Journal of Haematology|December 22, 2017
Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemiaWen Cui, Jin Wang, Rui-Min Nie, et al.
Pageof 7